×

Urologic Pathology in 2017: Emerging Concepts, WHO Classification and AJCC Updated




Evaluated by: David B. Kaminsky, M.D., FIAC on [DATE]
Last Day to purchase/claim credit: May 19, 2020.
CME / SAM 13.5

Narrative Description:
The WHO Classification of Tumors of the Urinary System and Male Genital Organs and updates by the American Joint Committee on Cancer are reference points for this extraordinary interactive microscopy course that explicates emerging concepts in the context of these classification/staging systems. The superb faculty are internationally recognized for their expertise in urologic pathology; collaboration with one of the most experienced surgeons in the United States performing robot-assisted radical cystectomy and urinary diversion for patients with bladder cancer provides an open, practical dialogue between clinician and the pathologist course director. This is an intimate experience that will change how you think and perform.

Take a definitive step towards understanding the intricacies and challenges of urologic pathology with this online course.

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians can earn a maximum of 13.5 AMA PRA Category 1 Credits ™ by participating in the CME activities within this Interactive Microscopy Course.

USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 13.5 SAM credit hours.

USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner have, or have had, within the past 12 months, which relates to the content of this educational activity and creates a conflict of interest.

There are no relevant conflicts reported.

USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner have, or have had, within the past 12 months, which relates to the content of this educational activity and creates a conflict of interest.

  • Donna E. Hansel, M.D., Ph.D. declares no conflict of interest to disclose.
  • John Cheville, M.D. declares no conflict of interest to disclose.
  • Michelle S. Hirsch, M.D., Ph.D. declares no conflict of interest to disclose.
  • Peter A. Humphrey, M.D., Ph.D. declares no conflict of interest to disclose.
  • Karim A. Kader, M.D., Ph.D. declares no conflict of interest to disclose.
  • John R. Srigley, M.D., FRCPC, FRCPath, FRCPA [Hon.] declares no conflict of interest to disclose.

Purchase the entire course and save - USCAP Members and Trainee Members, sign-in to save an additional amount!